Since 2019, many emerging consumer brands in China have achieved rapid early growth by capitalizing on readily available, low-cost online consumer traffic through content-driven customer acquisition, livestream commerce, and short-video recommendations. However, aside from a small number of strong frontrunners, most have struggled to sustain that momentum. From 2022 onward, as online customer acquisition costs rose and competition intensified, the limitations of shallow brand equity became increasingly apparent. Many once-hyped brands began to fade as quickly as they had risen.

This case examines the rise of Wuxi Dexter Biotechnology Co., Ltd. ("Dexter”), founded in 2017, which entered a niche category, leveraged emerging marketing platforms, and scaled rapidly within just four years. By 2021, Dexter's gross merchandise value (GMV) had exceeded ¥700 million, propelling the company into the first tier of China's maternal-and-infant wash and care market and establishing it as a benchmark brand within the segment. As a fast-rising entrant in the industry, what were the core drivers behind Dexter's rapid ascent?

By October 2024, however, the traffic dividend had largely run its course, while competitive pressures continued to intensify. In this new context, Dexter's central challenge became how to achieve long-term, stable development. As an emerging brand, it faced pressure not only from established incumbents but also from other fast-growing challengers, and had to withstand a deeper market test of both product capability and brand strength. Looking ahead, Dexter must consider how to move beyond a traffic-driven growth model, reinforce its brand moat, and build sustainable competitive advantages. Only by doing so can it remain a long-term winner rather than a short-lived market phenomenon.